Contraceptives Market

Contraceptives Market by Product, Gender, End User & Region - Forecast 2022 – 2032

Market Insights on Contraceptives covering sales outlook, demand forecast and up-to-date key trends

Request Sample

Contraceptive Market Outlook (2022-2032)

[200 Pages Report] Global contraceptive sales are expected to grow at a CAGR of 5.5%, and contraceptive drugs and devices are expected to reach US$ 30.8 Billion by 2032. In order to strengthen and improve family planning and reproductive health outcomes, W.H.O collaborates with partners at the global, regional, and country levels. As part of these partnerships, contraceptive tools and products will be made more accessible, family planning programs will be streamlined, and global commitments will be mobilized in order to address the unmet need for family planning.

Contraceptive services and programs are increasingly recognizing the importance of human rights. Providing high-quality contraceptive services, autonomy, and choice of methods as well as respecting the provision of care are some of the challenges faced by healthcare providers and facility managers in ensuring human rights aspects are integrated into their services.

The need for modern contraception is estimated to be unmet by 214 million women globally. Governments at regional and international levels provide access to contraceptive information, commodities, and services in the market. In addition, the government has been increasing its focus on information and services related to contraception over the past years. State officials are increasingly emphasizing on the importance of ensuring that contraceptive services are available in a timely and affordable manner in various regions.

Market Outlook:

Data Points	Market Insights
Contraceptives Market Base Year Value (2021)	US$ 17.3 Bn
Estimated Market Size (2022)	US$ 18.0 Bn
Projected Market Valuation (2032)	US$ 30.8 Bn
Value-based CAGR (2022-2032)	5.5%
Market Share of Top 5 Countries	53.3%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Research to Expand Contraception Access

The World Health Organization has launched an App that outlines its medical guidelines for contraception use. Women with medical conditions or medically-relevant characteristics will benefit from this digital tool by making it easier to recommend safe, effective, and acceptable contraceptives.

WHO published a report in 2017, with a user-friendly checklist that focuses on human rights standards in the provision of contraceptive information and services. As part of the checklist, healthcare providers focused on five areas of competence that were to be addressed.

During clinical trials, new types of contraceptive pills and gels will be introduced that are expected to work around new laws and limitations on current birth control procedures. Ultimately, research will concentrate on developing a non-hormonal pill that could expand the range of birth control options available to men.

Contraceptives Market

Oral Contraceptives are Experiencing Rapid Growth in the Market

Oral contraceptives are highly sought after by young people in developing nations. The number of government-sponsored programs and the free provision of contraceptives in rural and urban areas will encourage growth in the sale and use of these pills in the market.

In addition to the growing challenges associated with teenage pregnancies, increasing knowledge of modern contraception and the issue of unplanned pregnancies will continue to further bolster the market for oral pills.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Contraceptive Market Growth in the Future

Contraceptive use is expected to grow rapidly over the next five years. As new contraceptives are introduced and various research studies and governmental trials are conducted, the market for contraceptives is expected to be further boosted. Numerous factors may be responsible for the market's growth, including greater consumer awareness of STDs, unintended pregnancies, and population control. As a result of these factors, the demand for contraceptives will soar, particularly in developing countries.

In the future, self-injectable contraceptives will become more available as an additional solution for people of reproductive age who wish to obtain injectable contraceptives, which will further contribute to the growth of the contraceptive market. With the entry of new vendors and the increasing availability of advanced methods of contraception in the market, there is a good chance for the market to grow significantly in the future. With the improvement in the supply chain network of manufacturers, retail pharmacies will continue monopolizing the market.

The market value for contraceptives was approximately 43.1% of the overall US$ 40 Bn of the global sexual wellness market in 2021.

Demand for contraceptives is increasing due to the rising need for the prevention of unplanned pregnancy. A variety of factors, including sociodemographic parameters (age, residency, religion, educational and socioeconomic position), family traits and preferences (number of surviving children, intended family size), and family planning programme exposure are expected to influence contraceptive use.

The hazards of morbidity and mortality associated with pregnancy and delivery are well known. Contraceptives have both contraceptive and non-contraceptive health advantages. Oral contraceptives, for instance, not only prevent conception but also lower the chance of ovarian and endometrial cancer, as well as ectopic pregnancies.

2017-2021 Contraceptives Market Historic Outlook Vs 2022-2032 Forecast

Sales of contraceptives increased at a CAGR of 3.5% from 2017 to 2021, owing to the rising need to reduce teenage pregnancies.

Early pregnancy can also cause health problems for the new born. Babies born to adolescents are likely to be underweight before and at birth and are at higher risk of neonatal mortality.

According to the Centers for Disease Control and Prevention, mortality rates among infants born to adolescents aged 15 to 19 were greatest from 2017 to 2018, with 8.8 deaths per 1,000 live births, as compared to infants born to women aged 20 and up. Preterm birth, low birth weight, and congenital deformities contributed to these deaths.

The market is driven by various initiatives taken by governments across the globe to promote awareness and accessibility to birth control methods, or family planning. For instance, USAID (the U.S. Agency for International Development) advances and aids in family planning and reproductive health programs in approximately 40 countries across the globe.

Organizations such as the European Network, European Society of Contraception and Reproductive Health (ESC), United Nations Population Fund (UNFPA), the International Planned Parenthood Federation (IPPF), and the United States Agency for International Development (USAID) help in providing family planning guidance and adoption of WHO guidelines related to contraceptives.

According to WHO, around 842.0 million people are using contraceptive methods and 270.0 million people have an unmet need for contraception, out of 1.9 billion women of the reproductive age, globally, in 2019.

Apart from birth control, contraceptive products such as condoms can prevent the transmission of sexually transmitted infections, including HIV. For instance, according to the data provided by WHO, 37.7 million people were living with AIDS/HIV in the world in 2020. This can be reduced by using contraceptive products such as condoms.

The increasing need for contraception owing to higher awareness among the reproductive age group for birth control and family planning is expected to create opportunities for growth in the market over the forecast period.

What are the Key Opportunities for Manufacturers in the Contraceptives Market?

Sales of contraceptives are expected to rise due to the introduction of more effective male contraception products. Currently, female contraceptives are leading in the market but male contraceptives will witness high demand due to the increasing usage of male condoms.

The usage of condoms is increasing due to their dual role in both birth control and prevention of sexually transmitted diseases (STD). In addition to this, it has low to no side effects on the body.

A large number of women of reproductive age in developing countries have unmet needs, such as limited access to contraception, limited choice of methods, social and religious issues, poor quality of available services, and gender-based barriers. All these unmet needs can lead to a higher risk of unintended pregnancy.

As a result, manufacturers are aiming to expand their products and services across developing economies to improve sales.

What Factors are Restraining the Demand for Contraceptives?

Birth control drugs and devices have various side effects, such as spotting or bleeding between periods, most commonly from progestin-only pills, sore breasts, nausea, or headaches.

In rare cases, the side effects are very serious such as blood clots in the legs, heart attacks and stroke, liver disorders, and gallbladder disease. These side effects associated with the usage of contraceptives will limit sales over the forecast period.

Furthermore, lack of knowledge, misperceptions, lack of social acceptance, and exaggerated fears about the safety of contraceptive methods are major barriers to contraceptive use.

Moreover, oral contraceptives elevate the risk of heart disease. IUDs are effective contraception; however, they raise the risk of infection in some high-risk individuals. Barrier contraception is less effective than other forms of contraception, but it protects against sexually transmitted infections like HIV. Because of differences in the prevalence of the disorders implicated, the value of non-contraceptive benefits and hazards of contraceptives differs among nations.

Country-wise Insights

What is Driving the U.S. Contraceptives Market?

“Increasing Adoption of Female Condoms in the U.S. will Fuel Growth”

The U.S. dominated the North America contraceptives market, holding 92.8% of the total market share in 2021. As per the report, the trend is expected to continue over the forecast period.

The U.S. is one of the world's leading users and suppliers of contraceptives. The government has been involved in global family planning/reproductive health (FP/RH) activities for more than 50 years and is the world's largest donor in this field.

Moreover, the U.S. also increased their funding for FP/RH in the recent years. For instance, in 2020 U.S. funded approximately US$ 608.0 million for FP/RH, which includes funding for the United Nations Population Fund (UNFPA). Such initiatives are expected to bode well for the growth in the market.

Why is the Germany Contraceptives Market Considered Lucrative?

“Surging Demand for Contraceptive Devices in Germany Will Boost Growth”

Germany is set to exhibit a CAGR of nearly 5.5% in the Europe contraceptives market during the forecast period. Due to superior public health insurance, Germany is likely to be the most profitable market in the region. Birth control is covered by Germany's national health insurance for women under the age of 22.

Furthermore, contraceptive use is extremely common in the country. Due to outstanding access to online information and average availability to contraceptive supplies, Germany receives a 75.1 in the 2020 European Contraception Policy Atlas.

How is the China Contraceptives Market Faring?

“Rising Awareness Regarding Family Planning in China Will Spur Demand for Oral Contraceptives”

China accounted for about 43.4% of the East Asia contraceptives market share in 2021. Over the forecast period, demand for contraceptives is slated to grow at a 6.1% CAGR.

East & Southeast Asia and Pacific, which includes China, is expected to have the most married users (248 million), followed by Southern Asia (245.1 million), which includes India. With a rise in the number of married couples, the need for family planning comes into place.

China imported roughly 42.36 metric tonnes of hormonal contraceptive preparations in February 2022, up from just 5.28 metric tonnes the previous year. The total value of hormonal contraceptives imported in that month was 218.5 million yuan.

Better education and awareness among youth are also propelling the use of contraceptives in the country.

Category-wise Insights

Which Contraceptives Product is Driving Growth in the Market?

“Adoption of Contraceptive Devices Will Steer Sales in the Market”

By product type, the devices segment held a share of 58.3% in 2021. Over the assessment period, sales in this segment will increase at a CAGR of 5.5% through 2032.

Strong government promotions and initiatives for women's and children's health are propelling the usage of contraceptive devices. Government involvement in promoting family planning and contraception, particularly in emerging economies, is a crucial factor boosting the global contraceptives market.

Which Gender is Largely in Focus within the Contraceptives Market?

“Demand for Contraceptives Among Females Will Gain Traction”

Based on gender, the female segment accounted for about 74.9% of the total market share in 2021, and is expected to hold 74.3% in 2032. Female contraceptive methods are more popular than the male contraceptives because of their higher efficiency in preventing pregnancy.

According to American Sexual Health Association, male condoms are around 84% effective in preventing pregnancy, whereas pills are 92%-97% effective, implants are 99.9% effective, and IUDs are 99% effective.

Which Sales Channel Holds Maximum Share in the Contraceptives Market?

“Sales of Contraceptives through Retail Sales to Remain High”

In terms of sales channel, the retail sales segment held around 44.3% of the total market share in 2021. As per the report, total sales in this segment will account for nearly 44.4% of the total market share in 2032.

Contraceptives are widely sold through retail pharmacies, drug stores, and supermarkets/ hypermarkets. Integration of contraceptive delivery with other development programs, community-based distribution of contraceptives and commercial retail sales will push sales in this segment over the forecast period.

Competitive Landscape

Key players in the contraceptive market are concentrating on acquisitions and collaborations, and gaining FDA approvals as the key strategies for expanding their presence in the market.

These will support market players such as Cooper Surgical, Inc., AbbVie, and Exeltis USA, Inc. to improve their product portfolio together with market penetration. Some recent developments include:

In December 2021, Cooper Surgical, Inc. completed the acquisition of Generate Life Sciences. This acquisition helps Cooper to improve their reproductive segment.
In November 2020, AbbVie announced a partnership with the American College of Obstetricians and Gynaecologists, the Endometriosis Association, Healthy Women, the International Pelvic Pain Society, GE Healthcare, and the Black Women's Health Imperative to help improve the lives of the one in ten women of reproductive age in the United States who suffer from this disease.
In July 2019, Exeltis USA, Inc. gained approval from US Food and Drug Administration (FDA) for Slynd™, which is an oral contraceptive tablet for preventing pregnancy.

Report Scope as per Contraceptives Industry Analysis

Attribute	Details
Forecast Period	2017-2021
Historical Data Available for	2022-2032
Market Analysis	US$ Bn for Value
Key Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa
Key Countries Covered	The U.S., China, Japan, Germany, Canada, the U.K., India, South Korea, Russia, Australia, BENELUX, Spain, Indonesia, France, Italy, Brazil, Thailand, Malaysia, Mexico, GCC, Argentina, South Africa, Turkey, and New Zealand
Key Market Segments Covered	Product, Gender, End User, and Region
Key Companies Profiled	Bayer AG Pfizer Inc. Janssen Global Services, LLC Teva Pharmaceutical Industries Ltd. Merck & Co., Inc. Mylan N.V. Allergan Plc. Reckitt Benckiser Group plc. Veru Inc. Church & Dwight Co., Inc. Medisafe Distribution Inc. Cooper Surgical, Inc. Mayer Laboratories, Inc. Pfizer Inc. The Female Health Company Exeltis USA, Inc.

Key Market Segments Covered in Contraceptives Industry Research

By Product:

Drugs
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
Devices
- Condoms
- Diaphragms
- Contraceptive Sponges
- Vaginal Rings
- Cervical Cap
- Subdermal Implants
- Intra-uterine Devices
  - Copper
  - Hormonal

By Gender:

Female
Male

By End User:

Institutional Sales
- Hospitals
- Specialty Clinics
Retail Sales
- Retail Pharmacy
- Drug Stores
- Supermarkets/ Hypermarkets
Online Sales

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa (MEA)

Frequently Asked Questions

How much is the contraceptives market worth in 2022?

The global contraceptives market is projected to total US$ 18 Bn in 2022 and is set to expand 1.7X over the next ten years.

What is the sales forecast for contraceptives through 2032?

The contraceptives market is expected to reach US$ 30.8 Bn by 2032, with sales growing at a 5.5% CAGR.

What are the key trends shaping the contraceptives market?

Increasing rate of sexually transmitted diseases, the rise in the use of oral pills among teenagers, and rising government initiatives to promote maternal and child health, are some of the key trends in this market.

Which are the top 5 countries driving demand for contraceptives?

The U.S., China, India, Japan, and South Korea are expected to drive demand for the contraceptives industry.

What is the North American market outlook for contraceptives market?

North America is one of the key markets for contraceptives, with the U.S. expected to account for over 93.0% of the North American market in the year 2032.

At what percentage is the demand for contraceptives expected to register growth in Europe?

Demand for contraceptives in Europe is expected to register growth of 5.4% over the next ten years.

Which Countries are Key Producers of Contraceptive Products?

The U.S., China and the U.K. are key producers of contraceptives products.

Which are the Key Exporters of the Global Contraceptives Market?

Bayer AG Pfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc., Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Pfizer Inc., The Female Health Company, and Exeltis USA, Inc. are the key exporters of contraceptives market.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Value Added Insights

4.1. New Product Launches

4.2. New Technologies

4.3. Guidelines, Regulations and Reimbursement

4.4. Assessment of Unmet Needs

4.5. PESTEL Analysis

4.6. Porter’s Analysis

5. COVID-19 Crisis Analysis

5.1.1. Current COVID-19 Statistics and Probable Future Impact

5.1.2. COVID-19 and Impact Analysis

5.1.3. Revenue by Product

5.1.4. Revenue by Gender

5.1.5. Revenue by End User

5.1.6. Revenue by Region

6. Market Background

6.1. Macro-Economic Factors

6.1.1. Global GDP Outlook

6.1.2. Global Healthcare Spending Outlook

6.1.3. Global Pharmaceutical Outlook

6.2. Forecast Factors - Relevance & Impact

6.2.1. Adoption rate of Contraceptives

6.2.2. Rising Awareness Regarding Female Reproductive Health

6.2.3. Strategic Collaborations

6.2.4. Rising Reproductive Age Population

6.2.5. Rise of Healthcare Spending in Developing Economies

6.2.6. Frequency of Product Launches

6.2.7. Rise in Teenage Pregnancies

6.2.8. Growing Number of Product Manufacturers

6.3. Market Dynamics

6.3.1. Drivers

6.3.2. Restraints

6.3.3. Opportunity Analysis

7. Global Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032

7.1. Historical Market Volume (Units) Analysis, 2017–2021

7.2. Current and Future Market Volume (Units) Projections, 2022–2032

7.2.1. Y-o-Y Growth Trend Analysis

8. Global Contraceptives Market - Pricing Analysis

8.1. Regional Pricing Analysis By Product Type

8.2. Pricing Break-up

8.2.1. Manufacturer Level Pricing

8.2.2. Distributor Level Pricing

8.3. Global Average Pricing Analysis Benchmark

9. Global Contraceptives Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032

9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021

9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

9.2.1. Y-o-Y Growth Trend Analysis

9.2.2. Absolute $ Opportunity Analysis

10. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by Product

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product, 2017–2021

10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product, 2022–2032

10.3.1. Drugs

10.3.1.1. Oral Contraceptive Pills

10.3.1.2. Injectable Contraceptives

10.3.1.3. Topical Contraceptives

10.3.2. Devices

10.3.2.1. Condoms

10.3.2.2. Diaphragms

10.3.2.3. Contraceptive Sponges

10.3.2.4. Vaginal Rings

10.3.2.5. Cervical Cap

10.3.2.6. Subdermal Implants

10.3.2.7. Intra-uterine Devices

10.3.2.7.1. Copper

10.3.2.7.2. Hormonal

10.4. Market Attractiveness Analysis By Product

11. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by Gender

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn), By Gender, 2017–2021

11.3. Current and Future Market Size (US$ Mn) and Forecast By Gender, 2022–2032

11.3.1. Female

11.3.2. Male

11.4. Market Attractiveness Analysis By Gender

12. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by End User

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Mn), By End User, 2017–2021

12.3. Current and Future Market Size (US$ Mn) Forecast By End User, 2022–2032

12.3.1. Institutional Sales

12.3.1.1. Hospitals

12.3.1.2. Specialty Clinics

12.3.2. Retail Sales

12.3.2.1. Retail Pharmacy

12.3.2.2. Drug Stores

12.3.2.3. Supermarkets/ Hypermarkets

12.3.3. Online Sales

12.4. Market Attractiveness Analysis By End User

13. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by Region

13.1. Introduction

13.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2017–2021

13.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2022–2032

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. East Asia

13.3.5. South Asia

13.3.6. Oceania

13.3.7. Middle East and Africa (MEA)

13.4. Market Attractiveness Analysis By Region

14. North America Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

14.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

14.4.1. By Country

14.4.1.1. U.S.

14.4.1.2. Canada

14.4.2. By Product

14.4.3. By Gender

14.4.4. By End User

14.5. Market Attractiveness Analysis

14.5.1. By Country

14.5.2. By Product

14.5.3. By Gender

14.5.4. By End User

14.6. Market Trends

14.7. Key Market Participants - Intensity Mapping

14.8. Drivers and Restraints - Impact Analysis

14.9. Country Level Analysis & Forecast

14.9.1. U.S. Contraceptives Market Analysis

14.9.1.1. .Introduction

14.9.1.2. Market Analysis and Forecast by Market Taxonomy

14.9.1.2.1. By Product

14.9.1.2.2. By Gender

14.9.1.2.3. By End User

14.9.2. Canada Contraceptives Market Analysis

14.9.2.1. Introduction

14.9.2.2. Market Analysis and Forecast by Market Taxonomy

14.9.2.2.1. By Product

14.9.2.2.2. By Gender

14.9.2.2.3. By End User

15. Latin America Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

15.1. Introduction

15.2. Pricing Analysis

15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

15.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

15.4.1. By Country

15.4.1.1. Mexico

15.4.1.2. Brazil

15.4.1.3. Argentina

15.4.1.4. Rest of Latin America

15.4.2. By Product

15.4.3. By Gender

15.4.4. By End User

15.5. Market Attractiveness Analysis

15.5.1. By Country

15.5.2. By Product

15.5.3. By Gender

15.5.4. By End User

15.6. Market Trends

15.7. Key Market Participants - Intensity Mapping

15.8. Drivers and Restraints - Impact Analysis

15.9. Country Level Analysis & Forecast

15.9.1. Mexico Contraceptives Market Analysis

15.9.1.1. Introduction

15.9.1.2. Market Analysis and Forecast by Market Taxonomy

15.9.1.2.1. By Product

15.9.1.2.2. By Gender

15.9.1.2.3. By End User

15.9.2. Brazil Contraceptives Market Analysis

15.9.2.1. Introduction

15.9.2.2. Market Analysis and Forecast by Market Taxonomy

15.9.2.2.1. By Product

15.9.2.2.2. By Gender

15.9.2.2.3. By End User

15.9.3. Argentina Contraceptives Market Analysis

15.9.3.1. Introduction

15.9.3.2. Market Analysis and Forecast by Market Taxonomy

15.9.3.2.1. By Product

15.9.3.2.2. By Gender

15.9.3.2.3. By End User

16. Europe Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

16.1. Introduction

16.2. Pricing Analysis

16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

16.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

16.4.1. By Country

16.4.1.1. Germany

16.4.1.2. Italy

16.4.1.3. France

16.4.1.4. U.K.

16.4.1.5. Spain

16.4.1.6. BENELUX

16.4.1.7. Nordic Countries

16.4.1.8. Russia

16.4.1.9. Rest of Europe

16.4.2. By Product

16.4.3. By Gender

16.4.4. By End User

16.5. Market Attractiveness Analysis

16.5.1. By Country

16.5.2. By Product

16.5.3. By Gender

16.5.4. By End User

16.6. Market Trends

16.7. Key Market Participants - Intensity Mapping

16.8. Drivers and Restraints - Impact Analysis

16.9. Country Level Analysis & Forecast

16.9.1. Germany Contraceptives Market Analysis

16.9.1.1. Introduction

16.9.1.2. Market Analysis and Forecast by Market Taxonomy

16.9.1.2.1. By Product

16.9.1.2.2. By Gender

16.9.1.2.3. By End User

16.9.2. Italy Contraceptives Market Analysis

16.9.2.1. Introduction

16.9.2.2. Market Analysis and Forecast by Market Taxonomy

16.9.2.2.1. By Product

16.9.2.2.2. By Gender

16.9.2.2.3. By End User

16.9.3. France Contraceptives Market Analysis

16.9.3.1. Introduction

16.9.3.2. Market Analysis and Forecast by Market Taxonomy

16.9.3.2.1. By Product

16.9.3.2.2. By Gender

16.9.3.2.3. By End User

16.9.4. U.K. Contraceptives Market Analysis

16.9.4.1. Introduction

16.9.4.2. Market Analysis and Forecast by Market Taxonomy

16.9.4.2.1. By Product

16.9.4.2.2. By Gender

16.9.4.2.3. By End User

16.9.5. Spain Contraceptives Market Analysis

16.9.5.1. Introduction

16.9.5.2. Market Analysis and Forecast by Market Taxonomy

16.9.5.2.1. By Product

16.9.5.2.2. By Gender

16.9.5.2.3. By End User

16.9.6. BENELUX Contraceptives Market Analysis

16.9.6.1. Introduction

16.9.6.2. Market Analysis and Forecast by Market Taxonomy

16.9.6.2.1. By Product

16.9.6.2.2. By Gender

16.9.6.2.3. By End User

16.9.7. Nordic Countries & Russia Contraceptives Market Analysis

16.9.7.1. Introduction

16.9.7.2. Market Analysis and Forecast by Market Taxonomy

16.9.7.2.1. By Product

16.9.7.2.2. By Gender

16.9.7.2.3. By End User

16.9.8. Russia Contraceptives Market Analysis

16.9.8.1. Introduction

16.9.8.2. Market Analysis and Forecast by Market Taxonomy

16.9.8.2.1. By Product

16.9.8.2.2. By Gender

16.9.8.2.3. By End User

17. East Asia Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

17.1. Introduction

17.2. Pricing Analysis

17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

17.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

17.4.1. By Country

17.4.1.1. China

17.4.1.2. Japan

17.4.1.3. South Korea

17.4.2. By Product

17.4.3. By Gender

17.4.4. By End User

17.5. Market Attractiveness Analysis

17.5.1. By Country

17.5.2. By Product

17.5.3. By Gender

17.5.4. By End User

17.6. Market Trends

17.7. Key Market Participants - Intensity Mapping

17.8. Drivers and Restraints - Impact Analysis

17.9. Country Level Analysis & Forecast

17.9.1. China Contraceptives Market Analysis

17.9.1.1. Introduction

17.9.1.2. Market Analysis and Forecast by Market Taxonomy

17.9.1.2.1. By Product

17.9.1.2.2. By Gender

17.9.1.2.3. By End User

17.9.2. Japan Contraceptives Market Analysis

17.9.2.1. Introduction

17.9.2.2. Market Analysis and Forecast by Market Taxonomy

17.9.2.2.1. By Product

17.9.2.2.2. By Gender

17.9.2.2.3. By End User

17.9.3. South Korea Contraceptives Market Analysis

17.9.3.1. Introduction

17.9.3.2. Market Analysis and Forecast by Market Taxonomy

17.9.3.2.1. By Product

17.9.3.2.2. By Gender

17.9.3.2.3. By End User

18. South Asia Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

18.1. Introduction

18.2. Pricing Analysis

18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

18.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

18.4.1. By Country

18.4.1.1. India

18.4.1.2. Indonesia

18.4.1.3. Malaysia

18.4.1.4. Philippines

18.4.1.5. Thailand

18.4.1.6. Vietnam

18.4.1.7. Rest of South Asia

18.4.2. By Product

18.4.3. By Gender

18.4.4. By End User

18.5. Market Attractiveness Analysis

18.5.1. By Country

18.5.2. By Product

18.5.3. By Gender

18.5.4. By End User

18.6. Market Trends

18.7. Key Market Participants - Intensity Mapping

18.8. Drivers and Restraints - Impact Analysis

18.9. Country Level Analysis & Forecast

18.9.1. India Contraceptives Market Analysis

18.9.1.1. Introduction

18.9.1.2. Market Analysis and Forecast by Market Taxonomy

18.9.1.2.1. By Product

18.9.1.2.2. By Gender

18.9.1.2.3. By End User

18.9.2. Indonesia Contraceptives Market Analysis

18.9.2.1. Introduction

18.9.2.2. Market Analysis and Forecast by Market Taxonomy

18.9.2.2.1. By Product

18.9.2.2.2. By Gender

18.9.2.2.3. By End User

18.9.3. Malaysia Contraceptives Market Analysis

18.9.3.1. Introduction

18.9.3.2. Market Analysis and Forecast by Market Taxonomy

18.9.3.2.1. By Product

18.9.3.2.2. By Gender

18.9.3.2.3. By End User

18.9.4. Philippines Contraceptives Market Analysis

18.9.4.1. Introduction

18.9.4.2. Market Analysis and Forecast by Market Taxonomy

18.9.4.2.1. By Product

18.9.4.2.2. By Gender

18.9.4.2.3. By End User

18.9.5. Thailand Contraceptives Market Analysis

18.9.5.1. Introduction

18.9.5.2. Market Analysis and Forecast by Market Taxonomy

18.9.5.2.1. By Product

18.9.5.2.2. By Gender

18.9.5.2.3. By End User

18.9.6. Vietnam Contraceptives Market Analysis

18.9.6.1. Introduction

18.9.6.2. Market Analysis and Forecast by Market Taxonomy

18.9.6.2.1. By Product

18.9.6.2.2. By Gender

18.9.6.2.3. By End User

18.9.6.2.4.

18.9.7. Rest of South Asia Contraceptives Market Analysis

18.9.7.1. Introduction

18.9.7.2. Market Analysis and Forecast by Market Taxonomy

18.9.7.2.1. By Product

18.9.7.2.2. By Gender

18.9.7.2.3. By End User

19. Oceania Contraceptives Market 2017-2021 and Forecast 2022-2032

19.1. Introduction

19.2. Pricing Analysis

19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

19.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

19.4.1. By Country

19.4.1.1. Australia

19.4.1.2. New Zealand

19.4.2. By Product

19.4.3. By Gender

19.4.4. By End User

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Product

19.5.3. By Gender

19.5.4. By End User

19.6. Key Market Participants - Intensity Mapping

19.7. Drivers and Restraints - Impact Analysis

19.8. Country Level Analysis & Forecast

19.8.1. Australia Contraceptives Market Analysis

19.8.1.1. Introduction

19.8.1.2. Market Analysis and Forecast by Market Taxonomy

19.8.1.2.1. By Product

19.8.1.2.2. By Gender

19.8.1.2.3. By End User

19.8.2. New Zealand Contraceptives Market Analysis

19.8.2.1. Introduction

19.8.2.2. Market Analysis and Forecast by Market Taxonomy

19.8.2.2.1. By Product

19.8.2.2.2. By Gender

19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

20.1. Introduction

20.2. Pricing Analysis

20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

20.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

20.4.1. By Country

20.4.1.1. GCC Countries

20.4.1.2. Israel

20.4.1.3. Turkey

20.4.1.4. South Africa & North Africa

20.4.1.5. Rest of Middle East and Africa

20.4.2. By Product

20.4.3. By Gender

20.4.4. By End User

20.5. Market Attractiveness Analysis

20.5.1. By Country

20.5.2. By Product

20.5.3. By Gender

20.5.4. By End User

20.6. Market Trends

20.7. Key Market Participants - Intensity Mapping

20.8. Drivers and Restraints - Impact Analysis

20.9. Country Level Analysis & Forecast

20.9.1. GCC Countries Contraceptives Market Analysis

20.9.1.1. Introduction

20.9.1.2. Market Analysis and Forecast by Market Taxonomy

20.9.1.2.1. By Product

20.9.1.2.2. By Gender

20.9.1.2.3. By End User

20.9.2. Israel Contraceptives Market Analysis

20.9.2.1. Introduction

20.9.2.2. Market Analysis and Forecast by Market Taxonomy

20.9.2.2.1. By Product

20.9.2.2.2. By Gender

20.9.2.2.3. By End User

20.9.3. Turkey Contraceptives Market Analysis

20.9.3.1. Introduction

20.9.3.2. Market Analysis and Forecast by Market Taxonomy

20.9.3.2.1. By Product

20.9.3.2.2. By Gender

20.9.3.2.3. By End User

20.9.4. South Africa & North Africa Contraceptives Market Analysis

20.9.4.1. Introduction

20.9.4.2. Market Analysis and Forecast by Market Taxonomy

20.9.4.2.1. By Product

20.9.4.2.2. By Gender

20.9.4.2.3. By End User

20.9.5. Rest of MEA Contraceptives Market Analysis

20.9.5.1. Introduction

20.9.5.2. Market Analysis and Forecast by Market Taxonomy

20.9.5.2.1. By Product

20.9.5.2.2. By Gender

20.9.5.2.3. By End User

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies

21.2. Market Share Analysis of Top Players

21.3. Market Presence Analysis

22. Competition Analysis

22.1. Competition Dashboard

22.2. Competition Benchmarking

22.3. Competition Deep Dive

22.3.1. Bayer AG Pfizer Inc.

22.3.1.1. Overview

22.3.1.2. Product Portfolio

22.3.1.3. SWOT Analysis

22.3.1.4. Sales Footprint

22.3.1.5. Strategy Overview

22.3.1.6. Key financials

22.3.2. Janssen Global Product, LLC

22.3.2.1. Overview

22.3.2.2. Product Portfolio

22.3.2.3. SWOT Analysis

22.3.2.4. Sales Footprint

22.3.2.5. Strategy Overview

22.3.2.6. Key financials

22.3.3. Teva Pharmaceutical Industries Ltd.

22.3.3.1. Overview

22.3.3.2. Product Portfolio

22.3.3.3. SWOT Analysis

22.3.3.4. Sales Footprint

22.3.3.5. Strategy Overview

22.3.3.6. Key financials

22.3.4. Merck & Co., Inc.

22.3.4.1. Overview

22.3.4.2. Product Portfolio

22.3.4.3. SWOT Analysis

22.3.4.4. Sales Footprint

22.3.4.5. Strategy Overview

22.3.4.6. Key financials

22.3.5. Mylan N.V.

22.3.5.1. Overview

22.3.5.2. Product Portfolio

22.3.5.3. SWOT Analysis

22.3.5.4. Sales Footprint

22.3.5.5. Strategy Overview

22.3.5.6. Key financials

22.3.6. Allergan Plc.

22.3.6.1. Overview

22.3.6.2. Product Portfolio

22.3.6.3. SWOT Analysis

22.3.6.4. Sales Footprint

22.3.6.5. Strategy Overview

22.3.6.6. Key financials

22.3.7. Reckitt Benckiser Group plc.

22.3.7.1. Overview

22.3.7.2. Product Portfolio

22.3.7.3. SWOT Analysis

22.3.7.4. Sales Footprint

22.3.7.5. Strategy Overview

22.3.7.6. Key financials

22.3.8. Veru Inc.

22.3.8.1. Overview

22.3.8.2. Product Portfolio

22.3.8.3. SWOT Analysis

22.3.8.4. Sales Footprint

22.3.8.5. Strategy Overview

22.3.8.6. Key financials

22.3.9. Church & Dwight Co., Inc.

22.3.9.1. Overview

22.3.9.2. Product Portfolio

22.3.9.3. SWOT Analysis

22.3.9.4. Sales Footprint

22.3.9.5. Strategy Overview

22.3.9.6. Key financials

22.3.10. Medisafe Distribution Inc.

22.3.10.1. Overview

22.3.10.2. Product Portfolio

22.3.10.3. SWOT Analysis

22.3.10.4. Sales Footprint

22.3.10.5. Strategy Overview

22.3.10.6. Key financials

22.3.11. Cooper Surgical, Inc.

22.3.11.1. Overview

22.3.11.2. Product Portfolio

22.3.11.3. SWOT Analysis

22.3.11.4. Sales Footprint

22.3.11.5. Strategy Overview

22.3.11.6. Key financials

22.3.12. Mayer Laboratories, Inc.

22.3.12.1. Overview

22.3.12.2. Product Portfolio

22.3.12.3. SWOT Analysis

22.3.12.4. Sales Footprint

22.3.12.5. Strategy Overview

22.3.12.6. Key financials

22.3.13. Pfizer Inc.

22.3.13.1. Overview

22.3.13.2. Product Portfolio

22.3.13.3. SWOT Analysis

22.3.13.4. Sales Footprint

22.3.13.5. Strategy Overview

22.3.13.6. Key financials

22.3.14. The Female Health Company

22.3.14.1. Overview

22.3.14.2. Product Portfolio

22.3.14.3. SWOT Analysis

22.3.14.4. Sales Footprint

22.3.14.5. Strategy Overview

22.3.14.6. Key financials

22.3.15. Exeltis USA, Inc.

22.3.15.1. Overview

22.3.15.2. Product Portfolio

22.3.15.3. SWOT Analysis

22.3.15.4. Sales Footprint

22.3.15.5. Strategy Overview

22.3.15.6. Key financials

23. Assumptions and Acronyms Used

24. Research Methodology

List of Tables

Table 01: Global Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 02: Global Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 03: Global Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 04: Global Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 05: Global Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Region

Table 06: North America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 07: North America Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 08: North America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 09: North America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 10: North America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 11: Latin America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 12: Latin America Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 13: Latin America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 14: Latin America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 15: Latin America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 16: Europe Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 17: Europe Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 18: Europe Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 19: Europe Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 20: Europe Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 21: South Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 22: South Asia Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 23: South Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 24: South Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 25: South Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 26: East Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 27: East Asia Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 28: East Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 29: East Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 30: East Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 31: Oceania Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 32: Oceania Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 33: Oceania Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 34: Oceania Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 35: Oceania Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 36: MEA Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 37: MEA Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 38: MEA Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 39: MEA Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 40: MEA Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 01: Global Contraceptives Market Volume (in Units) Analysis, 2017–2021

Figure 02: Global Contraceptives Market Volume (in Units) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 03: Global Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 04: Mini Devices Pricing Analysis (US$) for Per Unit, by Country, 2021

Figure 05: Cone Devices Pricing Analysis (US$) for Per Unit, by Country, 2021

Figure 06: Balloon Catheter Devices Pricing Analysis (US$) for Per Unit, by Country, 2021

Figure 07: Bed Systems Pricing Analysis (US$) for Per Unit, by Country, 2021

Figure 08: Global Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 09: Global Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 10: Global Contraceptives Market Absolute $ Opportunity Analysis, 2022–2032

Figure 11: Global Contraceptives Market Analysis by Product–2022 & 2032

Figure 12: Global Contraceptives Market Y-o-Y Growth Projections by Product, 2022 – 2032

Figure 13: Global Contraceptives Market Attractiveness Analysis, by Product, 2022-2032

Figure 14: Global Contraceptives Market Analysis by Gender –2022 & 2032

Figure 15: Global Contraceptives Market Y-o-Y Growth Projections by Gender, 2022 – 2032

Figure 16: Global Contraceptives Market Attractiveness Analysis, by Gender, 2022-2032

Figure 17: Global Contraceptives Market Analysis by End User –2022 & 2032

Figure 18: Global Contraceptives Market Y-o-Y Growth Projections by End User, 2022 – 2032

Figure 19: Global Contraceptives Market Attractiveness Analysis, by End User, 2022-2032

Figure 20: Global Contraceptives Market Analysis by Region –2022 & 2032

Figure 21: Global Contraceptives Market Y-o-Y Growth Projections by Region, 2022 – 2032

Figure 22: Global Contraceptives Market Attractiveness Analysis, by Region, 2022-2032

Figure 23: North America Contraceptives Market Value Share, by Country (2022 E)

Figure 24: North America Contraceptives Market Value Share, by Product (2022 E)

Figure 25: North America Contraceptives Market Value Share, by Gender (2022 E)

Figure 26: North America Contraceptives Market Value Share, by End User (2022 E)

Figure 27: North America Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 28: North America Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 29: North America Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 30: North America Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 31: North America Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 32: North America Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 33: Latin America Contraceptives Market Value Share, by Country (2022 E)

Figure 34: Latin America Contraceptives Market Value Share, by Product (2022 E)

Figure 35: Latin America Contraceptives Market Value Share, by Gender (2022 E)

Figure 36: Latin America Contraceptives Market Value Share, by End User (2022 E)

Figure 37: Latin America Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 38: Latin America Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 39: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 40: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 41: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 42: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 43: Europe Contraceptives Market Value Share, by Country (2022 E)

Figure 44: Europe Contraceptives Market Value Share, by Product (2022 E)

Figure 45: Europe Contraceptives Market Value Share, by Gender (2022 E)

Figure 46: Europe Contraceptives Market Value Share, by End User (2022 E)

Figure 47: Europe Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 48: Europe Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 49: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 50: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 51: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 52: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 53: South Asia Contraceptives Market Value Share, by Country (2022 E)

Figure 54: South Asia Contraceptives Market Value Share, by Product (2022 E)

Figure 55: South Asia Contraceptives Market Value Share, by Gender (2022 E)

Figure 56: South Asia Contraceptives Market Value Share, by End User (2022 E)

Figure 57: South Asia Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 58: South Asia Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 59: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 60: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 61: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 62: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 63: East Asia Contraceptives Market Value Share, by Country (2022 E)

Figure 64: East Asia Contraceptives Market Value Share, by Product (2022 E)

Figure 65: East Asia Contraceptives Market Value Share, by Gender (2022 E)

Figure 66: East Asia Contraceptives Market Value Share, by End User (2022 E)

Figure 67: East Asia Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 68: East Asia Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 69: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 70: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 71: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 72: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 73: Oceania Contraceptives Market Value Share, by Country (2022 E)

Figure 74: Oceania Contraceptives Market Value Share, by Product (2022 E)

Figure 75: Oceania Contraceptives Market Value Share, by Gender (2022 E)

Figure 76: Oceania Contraceptives Market Value Share, by End User (2022 E)

Figure 77: Oceania Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 78: Oceania Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 79: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 80: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 81: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 82: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 83: MEA Contraceptives Market Value Share, by Country (2022 E)

Figure 84: MEA Contraceptives Market Value Share, by Product (2022 E)

Figure 85: MEA Contraceptives Market Value Share, by Gender (2022 E)

Figure 86: MEA Contraceptives Market Value Share, by End User (2022 E)

Figure 87: MEA Contraceptives Market Size (US$ Mn) Analysis, 2017–2021

Figure 88: MEA Contraceptives Market Size (US$ Mn) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 89: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 90: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 91: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 92: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 93: Global Contraceptives Market Value Proportion Analysis, by Countries, 2021

Figure 94: Global Contraceptives Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2032

Figure 95: U.S. Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 96: U.S. Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 97: U.S. Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 98: Canada Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 99: Canada Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 100: Canada Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 101: Brazil Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 102: Brazil Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 103: Brazil Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 104: Mexico Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 105: Mexico Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 106: Mexico Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 107: Argentina Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 108: Argentina Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 109: Argentina Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 110: Germany Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 111: Germany Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 112: Germany Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 113: Italy Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 114: Italy Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 115: Italy Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 116: France Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 117: France Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 118: France Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 119: U.K. Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 120: U.K. Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 121: U.K. Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 122: Spain Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 123: Spain Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 124: Spain Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 125: BENELUX Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 126: BENELUX Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 127: BENELUX Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 128: Russia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 129: Russia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 130: Russia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 131: India Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 132: India Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 133: India Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 134: Thailand Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 135: Thailand Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 136: Thailand Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 137: Indonesia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 138: Indonesia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 139: Indonesia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 140: Malaysia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 141: Malaysia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 142: Malaysia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 143: China Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 144: China Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 145: China Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 146: Japan Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 147: Japan Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 148: Japan Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 149: South Korea Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 150: South Korea Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 151: South Korea Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 152: Australia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 153: Australia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 154: Australia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 155: New Zealand Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 156: New Zealand Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 157: New Zealand Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 158: GCC Countries Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 159: GCC Countries Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 160: GCC Countries Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 161: Turkey Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 162: Turkey Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 163: Turkey Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 164: South Africa Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 165: South Africa Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 166: South Africa Contraceptives Market Share Analysis (%) by End User, 2022 & 2032